COMMVAULT SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that COMMVAULT SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $995.62M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $839.25M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | $784.59M | May 5, 2025 |
| FY2024 | Mar 31, 2022 | $769.59M | May 13, 2024 |
| FY2023 | Mar 31, 2021 | $723.47M | May 5, 2023 |
| FY2020 | Mar 31, 2020 | $164.75M | May 15, 2020 |
| FY2020 | Dec 31, 2019 | $176.35M | May 15, 2020 |
| FY2020 | Sep 30, 2019 | $167.58M | May 15, 2020 |
| FY2020 | Jun 30, 2019 | $162.20M | May 15, 2020 |
| FY2020 | Mar 31, 2019 | $181.43M | May 15, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $995.62M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $839.25M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | $784.59M | May 5, 2025 |
| FY2024 | Mar 31, 2022 | $769.59M | May 13, 2024 |
| FY2023 | Mar 31, 2021 | $723.47M | May 5, 2023 |
| FY2022 | Mar 31, 2020 | $670.89M | May 6, 2022 |
| FY2021 | Mar 31, 2019 | $710.96M | May 13, 2021 |
| FY2020 | Mar 31, 2018 | $699.39M | May 15, 2020 |
| FY2019 | Mar 31, 2017 | $645.01M | May 2, 2019 |
| FY2018 | Mar 31, 2016 | $593.77M | May 3, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $816.58M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $687.64M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | $649.19M | May 5, 2025 |
| FY2024 | Mar 31, 2022 | $655.73M | May 13, 2024 |
| FY2023 | Mar 31, 2021 | $614.10M | May 5, 2023 |
| FY2020 | Mar 31, 2020 | $138.16M | May 15, 2020 |
| FY2020 | Dec 31, 2019 | $145.83M | May 15, 2020 |
| FY2020 | Sep 30, 2019 | $136.34M | May 15, 2020 |
| FY2020 | Jun 30, 2019 | $133.48M | May 15, 2020 |
| FY2020 | Mar 31, 2019 | $147.75M | May 15, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $76.11M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $168.91M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | ($35.77M) | May 5, 2025 |
| FY2024 | Mar 31, 2022 | $33.62M | May 13, 2024 |
| FY2023 | Mar 31, 2021 | ($30.95M) | May 5, 2023 |
| FY2020 | Mar 31, 2020 | $8.94M | May 15, 2020 |
| FY2020 | Dec 31, 2019 | ($650.0K) | May 15, 2020 |
| FY2020 | Sep 30, 2019 | ($7.08M) | May 15, 2020 |
| FY2020 | Jun 30, 2019 | ($6.85M) | May 15, 2020 |
| FY2020 | Mar 31, 2019 | ($2.16M) | May 15, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $73.74M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $75.36M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | ($15.89M) | May 5, 2025 |
| FY2024 | Mar 31, 2022 | $41.57M | May 13, 2024 |
| FY2023 | Mar 31, 2021 | ($22.26M) | May 5, 2023 |
| FY2022 | Mar 31, 2020 | ($17.51M) | May 6, 2022 |
| FY2021 | Mar 31, 2019 | $4.91M | May 13, 2021 |
| FY2020 | Mar 31, 2018 | ($946.0K) | May 15, 2020 |
| FY2019 | Mar 31, 2017 | ($1.24M) | May 2, 2019 |
| FY2018 | Mar 31, 2016 | $4.11M | May 3, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $146.29M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $132.33M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | $141.85M | May 5, 2025 |
| FY2024 | Mar 31, 2022 | $153.62M | May 13, 2024 |
| FY2023 | Mar 31, 2021 | $133.40M | May 5, 2023 |
| FY2022 | Mar 31, 2020 | $110.02M | May 6, 2022 |
| FY2021 | Mar 31, 2019 | $92.65M | May 13, 2021 |
| FY2020 | Mar 31, 2018 | $91.03M | May 15, 2020 |
| FY2019 | Mar 31, 2017 | $79.56M | May 2, 2019 |
| FY2018 | Mar 31, 2016 | $69.29M | May 3, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $207.38M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $203.80M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | $170.29M | May 5, 2025 |
| FY2024 | Mar 31, 2022 | $177.18M | May 13, 2024 |
| FY2023 | Mar 31, 2021 | $123.96M | May 5, 2023 |
| FY2022 | Mar 31, 2020 | $88.46M | May 6, 2022 |
| FY2021 | Mar 31, 2019 | $110.18M | May 13, 2021 |
| FY2020 | Mar 31, 2018 | $84.17M | May 15, 2020 |
| FY2019 | Mar 31, 2017 | $100.04M | May 2, 2019 |
| FY2018 | Mar 31, 2016 | $84.41M | May 3, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.76M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $4.09M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | $3.24M | May 5, 2025 |
| FY2024 | Mar 31, 2022 | $3.91M | May 13, 2024 |
| FY2023 | Mar 31, 2021 | $8.18M | May 5, 2023 |
| FY2022 | Mar 31, 2020 | $3.20M | May 6, 2022 |
| FY2021 | Mar 31, 2019 | $6.56M | May 13, 2021 |
| FY2020 | Mar 31, 2018 | $7.05M | May 15, 2020 |
| FY2019 | Mar 31, 2017 | $6.42M | May 2, 2019 |
| FY2018 | Mar 31, 2016 | $6.28M | May 3, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.12B | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $943.91M | May 5, 2025 |
| FY2024 | Mar 31, 2023 | $782.57M | May 13, 2024 |
| FY2023 | Mar 31, 2022 | $816.08M | May 5, 2023 |
| FY2022 | Mar 31, 2021 | $904.17M | May 6, 2022 |
| FY2021 | Mar 31, 2020 | $845.08M | May 13, 2021 |
| FY2020 | Mar 31, 2019 | $822.45M | May 15, 2020 |
| FY2019 | Mar 31, 2018 | $818.64M | May 2, 2019 |
| FY2018 | Mar 31, 2017 | $829.88M | May 3, 2018 |
| FY2017 | Mar 31, 2016 | $714.57M | May 5, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $325.12M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $278.09M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | $186.10M | May 5, 2025 |
| FY2025 | Mar 31, 2022 | $255.83M | May 5, 2025 |
| FY2024 | Mar 31, 2021 | $394.03M | May 13, 2024 |
| FY2023 | Mar 31, 2020 | $411.90M | May 5, 2023 |
| FY2022 | Mar 31, 2019 | $391.30M | May 6, 2022 |
| FY2021 | Mar 31, 2018 | $404.06M | May 13, 2021 |
| FY2020 | Mar 31, 2017 | $466.93M | May 15, 2020 |
| FY2019 | Mar 31, 2016 | $421.61M | May 2, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $185.26M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $127.78M | May 5, 2025 |
| FY2025 | Mar 31, 2023 | $127.78M | May 5, 2025 |
| FY2024 | Mar 31, 2022 | $127.78M | May 13, 2024 |
| FY2023 | Mar 31, 2021 | $112.44M | May 5, 2023 |
| FY2022 | Mar 31, 2020 | $112.44M | May 6, 2022 |
| FY2020 | Mar 31, 2019 | $0 | May 15, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($1.13B) | May 5, 2025 |
| FY2025 | Mar 31, 2024 | ($1.06B) | May 5, 2025 |
| FY2024 | Mar 31, 2023 | ($1.06B) | May 13, 2024 |
| FY2023 | Mar 31, 2022 | ($898.70M) | May 5, 2023 |
| FY2022 | Mar 31, 2021 | ($665.77M) | May 6, 2022 |
| FY2021 | Mar 31, 2020 | ($553.79M) | May 13, 2021 |
| FY2020 | Mar 31, 2019 | ($485.49M) | May 15, 2020 |
| FY2019 | Mar 31, 2018 | ($373.68M) | May 2, 2019 |
| FY2018 | Mar 31, 2017 | ($215.68M) | May 3, 2018 |
| FY2017 | Mar 31, 2016 | ($197.96M) | May 5, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $302.10M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | $312.75M | May 5, 2025 |
| FY2024 | Mar 31, 2023 | $287.78M | May 13, 2024 |
| FY2023 | Mar 31, 2022 | $267.51M | May 5, 2023 |
| FY2022 | Mar 31, 2021 | $397.24M | May 6, 2022 |
| FY2021 | Mar 31, 2020 | $288.08M | May 13, 2021 |
| FY2020 | Mar 31, 2019 | $327.99M | May 15, 2020 |
| FY2019 | Mar 31, 2018 | $330.78M | May 2, 2019 |
| FY2018 | Mar 31, 2017 | $329.49M | May 3, 2018 |
| FY2018 | Mar 31, 2016 | $288.11M | May 3, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 1 | May 5, 2025 |
| FY2025 | Mar 31, 2024 | 3 | May 5, 2025 |
| FY2025 | Mar 31, 2023 | 0 | May 5, 2025 |
| FY2024 | Mar 31, 2022 | 0 | May 13, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 5, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 15, 2020 |
| FY2020 | Dec 31, 2019 | 0 | May 15, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 15, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 15, 2020 |
| FY2020 | Mar 31, 2019 | 0 | May 15, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 1 | May 5, 2025 |
| FY2025 | Mar 31, 2024 | 3 | May 5, 2025 |
| FY2025 | Mar 31, 2023 | 0 | May 5, 2025 |
| FY2024 | Mar 31, 2022 | 0 | May 13, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 5, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 15, 2020 |
| FY2020 | Dec 31, 2019 | 0 | May 15, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 15, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 15, 2020 |
| FY2020 | Mar 31, 2019 | 0 | May 15, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 44.10M | May 5, 2025 |
| FY2025 | Mar 31, 2024 | 43.55M | May 5, 2025 |
| FY2024 | Mar 31, 2023 | 44.14M | May 13, 2024 |
| FY2023 | Mar 31, 2022 | 44.51M | May 5, 2023 |
| FY2022 | Mar 31, 2021 | 46.48M | May 6, 2022 |
| FY2021 | Mar 31, 2020 | 46.01M | May 13, 2021 |
| FY2020 | Mar 31, 2019 | 45.58M | May 15, 2020 |
| FY2019 | Mar 31, 2018 | 45.12M | May 2, 2019 |
| FY2018 | Mar 31, 2017 | 44.82M | May 3, 2018 |
| FY2017 | Mar 31, 2016 | 44.13M | May 5, 2017 |